Hidradenitis suppurativa Epidemiology, clinical presentation, and pathogenesis
Goldburg S, Strober B, Payette M. Hidradenitis suppurativa Epidemiology, clinical presentation, and pathogenesis. Journal Of The American Academy Of Dermatology 2019, 82: 1045-1058. PMID: 31604104, DOI: 10.1016/j.jaad.2019.08.090.Peer-Reviewed Original ResearchMeSH KeywordsAcademic Medical CentersComorbidityCytokinesEducation, Medical, ContinuingFemaleHidradenitis SuppurativaHumansIncidenceMaleQuality of LifeRisk AssessmentSeverity of Illness IndexUnited StatesConceptsClinical presentationPilosebaceous-apocrine unitPathogenesis of HSRole of cytokinesMedical education seriesQuality of lifeSinus tractPerianal areaInflammatory cytokinesInflammatory disordersHS pathogenesisFollicular hyperkeratosisInguinal areaLesion formationSubmammary foldPathogenesisCytokinesEducation seriesEpidemiologyPresentationRecent understandingPathogenic microorganismsSuppurativaAbscessPainHidradenitis suppurativa Current and emerging treatments
Goldburg S, Strober B, Payette M. Hidradenitis suppurativa Current and emerging treatments. Journal Of The American Academy Of Dermatology 2019, 82: 1061-1082. PMID: 31604100, DOI: 10.1016/j.jaad.2019.08.089.Peer-Reviewed Original ResearchConceptsHidradenitis suppurativaPathogenesis of HSNumerous clinical trialsPotential therapeutic roleMedical education seriesAnticytokine therapyTreatment optionsHS pathogenesisClinical trialsTherapeutic roleNovel therapiesNew therapiesTherapyPathogenesisEducation seriesRecent studiesTreatmentSuppurativaSurgeryCytokinesEtiologyTrials